Inspira Technologies Oxy B.H.N.
Ticker(s):
IINNW and IINN
Country:
Sector & Industry:
Business Overview
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels. The company has a strategic collaboration with Westchester Medical Center to advance critical patient care with the deployment of Inspira’s proprietary INSPIRA ART100 systems. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra’anana, Israel.
Contact & Other Information
Number of Employees:
37
Website:
,
,
Inspira Technologies entered into a sales agreement with A.G.P./Alliance Global Partners to offer and sell ordinary shares up to $1,019,000 for general corporate purposes.
03/14/2025 | 6-K | 0001013762-25-000316 |Inspira Technologies released a CEO update highlighting milestones in respiratory care technology, particularly the INSPIRA ART500 system and its potential to transform critical care.